当前位置:主页 > 医学论文 > 妇产科论文 >

重组人干扰素α2b阴道泡腾胶囊治疗宫颈人乳头瘤病毒感染的临床研究

发布时间:2018-09-18 10:47
【摘要】:目的评价重组人干扰素α2b阴道泡腾胶囊对宫颈人乳头瘤病毒(HPV)感染的疗效。方法 128例宫颈HPV感染患者随机分为试验组(62例)和对照组(66例)。试验组患者于末次月经干净3 d后,在阴道内放置重组人干扰素α2b阴道泡腾胶囊,每晚1粒,10 d为1个疗程,持续3个疗程。对照组患者予以定期随访观察,未做处理。3个疗程后,比较2组宫颈HPV阴转率、宫颈糜烂程度及不良反应。结果 3个疗程后,试验组HPV-DNA转阴48例,阴转率为77.4%,对照组HPV-DNA自行转阴4例,阴转率为6.1%,试验组阴转率显著高于对照组(P0.05);试验组宫颈糜烂面积缩小者30例,有效率为63.8%(30/47),对照组宫颈糜烂面积缩小者4例,有效率为8.3%(4/48),试验组有效率显著高于对照组(P0.05)。试验组患者无明显不良反应发生。结论重组人干扰素α2b阴道泡腾胶囊对宫颈HPV感染疗效显著,同时可减轻患者宫颈糜烂程度。
[Abstract]:Objective to evaluate the efficacy of recombinant human interferon 伪 2b vaginal effervescent capsule in the treatment of cervical human papillomavirus (HPV) infection. Methods 128 patients with cervical HPV infection were randomly divided into trial group (n = 62) and control group (n = 66). Patients in the test group were treated with recombinant human interferon 伪 2b vaginal effervescent capsule after the last menstruation for 3 days. The patients in the control group were followed up regularly without treatment. After 3 courses of treatment, the negative rate of cervical HPV, the degree of cervical erosion and the adverse reaction were compared between the two groups. Results after three courses of treatment, 48 cases of HPV-DNA turned negative in the trial group, the negative conversion rate was 77.4%, and 4 cases in the control group turned negative spontaneously, the negative conversion rate was 6.1%, the negative conversion rate in the test group was significantly higher than that in the control group (P0.05), 30 cases in the trial group had reduced cervical erosion area. The effective rate was 63.8% (30 / 47). In the control group, the area of cervical erosion was reduced in 4 cases, and the effective rate was 8.3% (4 / 48). The effective rate in the experimental group was significantly higher than that in the control group (P0.05). There was no significant adverse reaction in the trial group. Conclusion Recombinant human interferon 伪 2b vaginal effervescent capsule is effective in the treatment of cervical HPV infection and can reduce the degree of cervical erosion.
【作者单位】: 浙江省长兴县妇幼保健院妇产科;福建医科大学附属第一医院妇产科;
【基金】:福建省教育厅科技基金资助项目(JA12145)
【分类号】:R711.74

【相似文献】

相关期刊论文 前10条

1 ;慎用免疫增强剂:干扰素和中药同时服用有危险[J];中国社区医师;2003年12期

2 张惠芸,吕卉,李新民,段红英;干扰素α1b治疗慢性乙型肝炎纤维化的疗效观察[J];中华肝脏病杂志;2003年02期

3 周土凤;重组干扰素α-2a栓用于术前阴道清洁[J];中国医院药学杂志;2004年05期

4 郭秀侠,董义兰;外用重组人干扰素α2a凝胶剂研究[J];微生物学杂志;2005年03期

5 侯云德;干扰素研究的意义[J];中华实验和临床病毒学杂志;2005年03期

6 卢年芳;黄爱龙;唐霓;郑瑞强;林华;朱亚彬;吴莹;陶鹏;;干扰素α抗病毒活性的实验研究[J];中华肝脏病杂志;2005年12期

7 许正锯,杨红,陈真,张启华,陈先礼,李树清,王崇国;乙型肝炎病毒基因型与干扰素α1b疗效关系的研究[J];胃肠病学和肝病学杂志;2005年01期

8 柴庆君;;注射重组人干扰素α2b后常见反应的护理[J];吉林医学;2006年04期

9 Ferenci P.;Formann E.;Laferl H.;刘丽娜;;干扰素α-2a加利巴韦林联用或不用金刚烷胺对慢性丙型肝炎病毒基因1型感染者的治疗:一项随机、双盲、安慰剂对照研究[J];世界核心医学期刊文摘(胃肠病学分册);2006年05期

10 李晓东;李梵;韩萍;张健;臧红;陈国凤;徐东平;;聚乙二醇干扰素α2a治疗慢性乙型肝炎病毒学应答的相关分子研究[J];解放军医学杂志;2009年10期

相关会议论文 前10条

1 周岳进;;慢性乙型病毒性肝炎干扰素初治失败后的治疗[A];中国中西医结合学会第十二次全国消化系统疾病学术研讨会论文汇编[C];2000年

2 贾珍容;徐雪元;闵e,

本文编号:2247665


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/2247665.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户fb7c4***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com